Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Prostate
Real World Data
Completion Date
2017
Uploaded 09-01-2021
Available for Download
PDS UID: Prostat_Asociac_484
Intermittent hormonal therapy of prostate cancer patients in Spain: a prevalence study
Provider Information
Provider Data DescriptionWe estimated the use of the intermittent androgen deprivation therapy (%IAD) and the prevalence of patients under intermittent androgen therapy (PIAD) overall and stratified by region.
SponsorAsociación Colaboración Cochrane Iberoamericana (ACCIb)
Data ProviderAsociación Colaboración Cochrane Iberoamericana (ACCIb)
Partial set or SubsetOriginal Data
Patients in dataset65752
DOIhttps://doi.org/10.34949/fzzk-ye57
Data StandardNot CDISC
Files:
PROTOCOLCEIC_PROTOCOLO_Ca prostat.pdf
CRFIAD_CRF_v1.docx
Data DictionaryDataDescription_v1.xlsx
DATA (ACTIVE ARM)BBDD_Spain_IAD_v4.xlsx
© 2023 Project Data Sphere
All rights reserved
Privacy PolicyTerms of Use